The 309th Hospital of Chinese People's Liberation Army · 1×
×1.23k/2kID
×3.6386/106ASZ
×2.78/3DD
×0.8235/292CAM
×1.0170/168PS
Citations per year
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
'26
Countries citing scholars working at China National Pharmaceutical Group Corporation (China)
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at China National Pharmaceutical Group Corporation (China). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at China National Pharmaceutical Group Corporation (China) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites China National Pharmaceutical Group Corporation (China) more than expected).
Fields of papers published by authors at China National Pharmaceutical Group Corporation (China)
This network shows the impact of papers affiliated with China National Pharmaceutical Group Corporation (China) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with China National Pharmaceutical Group Corporation (China) at the time of their publication.
About China National Pharmaceutical Group Corporation (China)
In recent decades, authors affiliated with China National Pharmaceutical Group Corporation (China) have published 632 papers, which have received a total of 9.3k indexed citations . Scholars at this organization have produced 6 papers in Microbiology, 32 papers in Complementary and alternative medicine, 30 papers in Animal Science and Zoology, 38 papers in Pharmacology and 23 papers in Analytical Chemistry on the topics of Animal Virus Infections Studies (28 papers), Traditional Chinese Medicine Analysis (26 papers), Microbial Natural Products and Biosynthesis (22 papers), SARS-CoV-2 and COVID-19 Research (18 papers), Analytical Methods in Pharmaceuticals (17 papers), Advanced biosensing and bioanalysis techniques (15 papers), Influenza Virus Research Studies (12 papers) and Advanced Drug Delivery Systems (10 papers). Their work is cited by papers focused on Infectious Diseases (2.5k citations), Animal Science and Zoology (386 citations), Drug Discovery (8 citations), Complementary and alternative medicine (235 citations) and Pharmaceutical Science (170 citations). Authors at China National Pharmaceutical Group Corporation (China) collaborate with scholars in China, United States and United Kingdom and have published in prestigious journals including Scientific Reports, International Journal of Biological Macromolecules, Journal of Ethnopharmacology, Nature Communications and Poultry Science. Some of China National Pharmaceutical Group Corporation (China)'s most productive authors include Chunzhao Liu, Fuchao Chen, Bin Zhang, Benhong Zhou, Peng Chen, Jianqiang Ye, Aijian Qin, Bin Zhang, Yan Zhao and Jiexin Lei.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact